[Hypertrophic septal cardiomyopathy, the great simulator]

Area of Science:

• Cardiology
• Genetics
• Molecular Biology

Background:

• Hypertrophic cardiomyopathy (HCM) is a primary genetic heart muscle disease affecting 60-70% of patients.
• It stems from mutations in sarcomere genes, impacting the heart's contractile apparatus.
• HCM is characterized by unexplained disproportionate cardiac muscle thickening.

Observation:

• Clinical presentations of HCM are highly variable, ranging from asymptomatic cases to severe outcomes like heart failure or sudden cardiac death.
• The condition often leads to dynamic left ventricular outflow obstruction due to hypertrophy and abnormal ventricular shape.
• Hypertrophic septal cardiomyopathy is noted as a frequent yet under-diagnosed subtype.

Findings:

• Genetic mutations in sarcomere proteins are the primary cause of HCM.
• Left ventricular outflow tract obstruction is a common complication.
• Variable clinical phenotypes necessitate tailored management strategies.

Implications:

• Risk stratification for sudden cardiac death is essential for patient management.
• Genetic screening can identify at-risk individuals and families.
• Therapeutic interventions focus on reducing outflow obstruction and include lifestyle modifications, pharmacotherapy, and risk assessment.